Manulife Hong Kong and Macau appoints Ji Rongdao as Deputy CEO

Manulife Hong Kong and Macau announced that Jeffrey Kee has been appointed Deputy CEO and will continue to serve as Chief Financial Officer for Hong Kong and Macau.

The company stated that this appointment further enhances the strength of the leadership team and will help the company achieve its long-term growth goals and strategic focus in the Hong Kong and Macau markets.

As his responsibilities expand, Jeffrey Kee will work closely with the CEO to drive corporate integration, strengthen governance oversight, and ensure that the company’s strategic priorities align with daily operations. He will also represent the CEO on several dedicated committees to promote collaboration across related business areas and will continue to be a senior member of Manulife Hong Kong and Macau management.

Additionally, Jeffrey Kee will continue to lead the finance function, overseeing financial accounting and reporting, financial planning and analysis, treasury, corporate actuarial, capital and asset-liability management, and other finance-related matters. He is also responsible for leading distribution compensation and business data analysis to promote performance management and accountability culture.

Jeffrey Kee joined Manulife in 2013 and has held various leadership roles in Hong Kong and Macau, covering pricing, product, and health businesses. He previously served as Chief Product Officer and later as Health Business Head.

Manulife Hong Kong and Macau CEO White Kai-wing stated that Jeffrey Kee’s expanded responsibilities reflect his significant influence across various business areas of the company, and he believes this will further help the company achieve its long-term growth objectives.